Review



human igg1 kappa, isotype control  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    MedChemExpress human igg1 kappa, isotype control
    Human Igg1 Kappa, Isotype Control, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 40 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+igg1+isotype+control/Human+IgG1+kappa%2C+Isotype+Control/custom%40hy-p99001%4042526440
    Average 95 stars, based on 40 article reviews
    human igg1 kappa, isotype control - by Bioz Stars, 2026-09
    95/100 stars

    Images

    Related Articles

    Control:

    Article Title: 89 Zr/ 177 Lu-Labeled Radioimmunoconjugates Targeting SORT1 for Cancer Theranostics.
    Article Snippet: Sortilin (SORT1), a receptor overexpressed across multiple malignancies, represents a promising but untapped target for radionuclide theranostics.. We utilized the SORT1-targeted antibody latozinemab to develop [89Zr]Zr-DFO-latozinemab and [177Lu]Lu-DOTA-latozinemab, providing a proof-ofconcept for SORT1-targeted theranostics.. Transcriptional analyses confirmed significant SORT1 upregulation across multiple malignancies, notably in melanoma.

    Article Title: EBV infection outcomes determined by monocyte and TREG-driven immune dynamics in an ex vivo pbmc model.
    Article Snippet: Vopikitug (RG6292; MedChemExpress, Cat# HY-P990086) was used at 800 ng/mL, diluted in RPMI cell culture medium [58]. .. An equivalent concentration of human IgG1 isotype control (MedChemExpress, Cat# HYP99001) was used in control conditions (Mock and EBV). ..

    Article Title: EBV infection outcomes determined by monocyte and T REG -driven immune dynamics in an ex vivo pbmc model
    Article Snippet: Vopikitug (RG6292; MedChemExpress, Cat# HY-P990086) was used at 800 ng/mL, diluted in RPMI cell culture medium [ ]. .. An equivalent concentration of human IgG1 isotype control (MedChemExpress, Cat# HY-P99001) was used in control conditions (Mock and EBV). ..

    Article Title: EBV INFECTION OUTCOMES DETERMINED BY MONOCYTE AND T REG -DRIVEN IMMUNE DYNAMICS IN AN EX VIVO PBMC MODEL
    Article Snippet: Vopikitug (RG6292; MedChemExpress, Cat# HY-P990086) was used at 800 ng/mL, diluted in RPMI cell culture medium [ ]. .. An equivalent concentration of human IgG1 isotype control (MedChemExpress, Cat# HY-P99001) was used in control conditions (Mock and EBV). ..

    Concentration Assay:

    Article Title: EBV infection outcomes determined by monocyte and TREG-driven immune dynamics in an ex vivo pbmc model.
    Article Snippet: Vopikitug (RG6292; MedChemExpress, Cat# HY-P990086) was used at 800 ng/mL, diluted in RPMI cell culture medium [58]. .. An equivalent concentration of human IgG1 isotype control (MedChemExpress, Cat# HYP99001) was used in control conditions (Mock and EBV). ..

    Article Title: EBV infection outcomes determined by monocyte and T REG -driven immune dynamics in an ex vivo pbmc model
    Article Snippet: Vopikitug (RG6292; MedChemExpress, Cat# HY-P990086) was used at 800 ng/mL, diluted in RPMI cell culture medium [ ]. .. An equivalent concentration of human IgG1 isotype control (MedChemExpress, Cat# HY-P99001) was used in control conditions (Mock and EBV). ..

    Article Title: EBV INFECTION OUTCOMES DETERMINED BY MONOCYTE AND T REG -DRIVEN IMMUNE DYNAMICS IN AN EX VIVO PBMC MODEL
    Article Snippet: Vopikitug (RG6292; MedChemExpress, Cat# HY-P990086) was used at 800 ng/mL, diluted in RPMI cell culture medium [ ]. .. An equivalent concentration of human IgG1 isotype control (MedChemExpress, Cat# HY-P99001) was used in control conditions (Mock and EBV). ..



    Similar Products

    95
    MedChemExpress human igg1 kappa, isotype control
    Human Igg1 Kappa, Isotype Control, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+igg1+isotype+control/Human+IgG1+kappa%2C+Isotype+Control/custom%40hy-p99001%4042526440
    Average 95 stars, based on 1 article reviews
    human igg1 kappa, isotype control - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec non relevant isotype matched rea control antibody
    Non Relevant Isotype Matched Rea Control Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+igg1+isotype+control/REA+Control+Antibody%2C+human+IgG1%2C+REAfinity/pm42415077-158-6-12
    Average 96 stars, based on 1 article reviews
    non relevant isotype matched rea control antibody - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    95
    MedChemExpress isotype control human igg
    Isotype Control Human Igg, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+igg1+isotype+control/Human+IgG1+kappa%2C+Isotype+Control/pm42440198-84-28-33
    Average 95 stars, based on 1 article reviews
    isotype control human igg - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec isotype control
    Isotype Control, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+igg1+isotype+control/REA+Control+Antibody+(S)%2C+human+IgG1%2C+REAfinity/bio_rxiv__64898__2026__05__21__726982-88-15-20
    Average 96 stars, based on 1 article reviews
    isotype control - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    95
    MedChemExpress human igg1 kappa isotype control
    Human Igg1 Kappa Isotype Control, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+igg1+isotype+control/Human+IgG1+kappa%2C+Isotype+Control/pm42096614-80-8-6
    Average 95 stars, based on 1 article reviews
    human igg1 kappa isotype control - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    95
    MedChemExpress isotype matched control antibody
    Isotype Matched Control Antibody, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+igg1+isotype+control/Human+IgG1+kappa%2C+Isotype+Control/pm42009970-179-34-37
    Average 95 stars, based on 1 article reviews
    isotype matched control antibody - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec rea human igg1 isotype control apc
    Characterization of indicator antibodies by FIDA using different concentrations. A) Taylorgram showing relative fluorescence units (RFU) over time for increasing concentration of anti‐CD63 AF647, 0.88 nM (Rh: 5.24 nm); 1.66 nM (Rh: 5.41 nm); 3.33 nM (Rh: 5.37 nm) and 6.67 nM (Rh: 5.38 nm). B) Taylorgram showing relative fluorescence units (RFU) over time for 0.1–10 nM <t>IgG1‐APC.</t> C) Taylorgram showing relative fluorescence units (RFU) over time for 1–40 nM Cetuximab ALC647.
    Rea Human Igg1 Isotype Control Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+igg1+isotype+control/REA+Control+Antibody+(S)%2C+human+IgG1%2C+REAfinity/pmc13088886-184-46-52
    Average 96 stars, based on 1 article reviews
    rea human igg1 isotype control apc - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec recombinant bmi1 igg1 rea438 apc miltenyi biotec 130 124 301 isotype control mouse igg1κ
    Characterization of indicator antibodies by FIDA using different concentrations. A) Taylorgram showing relative fluorescence units (RFU) over time for increasing concentration of anti‐CD63 AF647, 0.88 nM (Rh: 5.24 nm); 1.66 nM (Rh: 5.41 nm); 3.33 nM (Rh: 5.37 nm) and 6.67 nM (Rh: 5.38 nm). B) Taylorgram showing relative fluorescence units (RFU) over time for 0.1–10 nM <t>IgG1‐APC.</t> C) Taylorgram showing relative fluorescence units (RFU) over time for 1–40 nM Cetuximab ALC647.
    Recombinant Bmi1 Igg1 Rea438 Apc Miltenyi Biotec 130 124 301 Isotype Control Mouse Igg1κ, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+igg1+isotype+control/BMI-1+Antibody%2C+anti-human%2C+REAfinity/pm41991735-194-0-5
    Average 93 stars, based on 1 article reviews
    recombinant bmi1 igg1 rea438 apc miltenyi biotec 130 124 301 isotype control mouse igg1κ - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    Image Search Results


    Characterization of indicator antibodies by FIDA using different concentrations. A) Taylorgram showing relative fluorescence units (RFU) over time for increasing concentration of anti‐CD63 AF647, 0.88 nM (Rh: 5.24 nm); 1.66 nM (Rh: 5.41 nm); 3.33 nM (Rh: 5.37 nm) and 6.67 nM (Rh: 5.38 nm). B) Taylorgram showing relative fluorescence units (RFU) over time for 0.1–10 nM IgG1‐APC. C) Taylorgram showing relative fluorescence units (RFU) over time for 1–40 nM Cetuximab ALC647.

    Journal: Journal of Extracellular Vesicles

    Article Title: In‐Solution Characterization of Extracellular Vesicles: A New Approach to Evaluating Antibody Binding and Surface Interactions

    doi: 10.1002/jev2.70269

    Figure Lengend Snippet: Characterization of indicator antibodies by FIDA using different concentrations. A) Taylorgram showing relative fluorescence units (RFU) over time for increasing concentration of anti‐CD63 AF647, 0.88 nM (Rh: 5.24 nm); 1.66 nM (Rh: 5.41 nm); 3.33 nM (Rh: 5.37 nm) and 6.67 nM (Rh: 5.38 nm). B) Taylorgram showing relative fluorescence units (RFU) over time for 0.1–10 nM IgG1‐APC. C) Taylorgram showing relative fluorescence units (RFU) over time for 1–40 nM Cetuximab ALC647.

    Article Snippet: EV samples (FLuoEVs, ciMSC‐EVs, Fc‐EVs, and Control EVs) were diluted in assay buffer to the respective concentration based on the particle concentration determined by NTA and/or IFCM followed by incubation with the respective antibodies: mouse anti‐human CD63 AF647 (H5C6, BD Biosciences, Cat. No. 561983, Herlev, Denmark), REA human IgG1 isotype control‐APC (REA293, Miltenyi Biotech, Cat. No. 130‐113‐434, Bergisch Gladbach, Germany) and Cetuximab (ERBITUX, 500 mg/100 mL Cetuximab, Cat. # 06185153) manually labeled with ALC647.

    Techniques: Fluorescence, Concentration Assay

    Binding measurements of increasing concentrations of IgG1‐APC and Cetuximab ALC647 to 1.02 × 10 9 p/mL CD63‐mNG‐Fc EVs. A) Changes of the hydrodynamic radius (Rh) of the complex of CD63‐mNG‐Fc EVs with IgG1‐APC in increasing concentrations of antibody, at 50 mbar ( n = 3). B) Percentage of bound IgG1‐APC by increasing concentrations of antibody to CD63‐mNG‐Fc EVs, at 50 mbar ( n = 3), r 2 = 0.9115. C) Area free/bound IgG1 antibody when incubated with CD63‐mNG‐Fc EVs on increasing concentrations, at 50 mbar ( n = 3), r 2 = 0.9997. D) Changes of the hydrodynamic radius (Rh) of the complex of CD63‐mNG‐Fc EVs with IgG1‐APC in increasing concentrations of antibody, at 100 mbar ( n = 3). E) Percentage of bound IgG1‐APC by increasing concentrations of antibody to CD63‐mNG‐Fc EVs, at 100 mbar ( n = 3), r 2 = 0.8818. F) Area free/bound IgG1 antibody when incubated with CD63‐mNG‐Fc EVs on increasing concentrations, at 100 mbar ( n = 3), r 2 = 0.9996. G) Changes of the hydrodynamic radius (Rh) of the complex of CD63‐mNG‐Fc EVs with Cetuximab in increasing antibody concentrations, at 50 mbar ( n = 3). H) Percentage of bound Cetuximab by increasing concentrations of antibody to CD63‐mNG‐Fc EVs, at 50 mbar ( n = 3), r 2 = 0.9851. I) Area free/bound Cetuximab ALC647 antibody when incubated with CD63‐mNG‐Fc EVs on increasing concentrations, at 50 mbar ( n = 3), r 2 = 0.9950 respectively. J) Changes of the hydrodynamic radius (Rh) of the complex of CD63‐mNG‐Fc EVs with Cetuximab in increasing antibody concentrations, at 100 mbar ( n = 3). K) Percentage of bound Cetuximab antibodies by increasing concentrations of antibody to CD63‐mNG‐Fc EVs, at 100 mbar ( n = 3), r 2 = 0.9537. L) Area free/bound Cetuximab ALC647 antibody when incubated with CD63‐mNG‐Fc EVs on increasing concentrations, at 100 mbar ( n = 3), r 2 = 0.9926, respectively.

    Journal: Journal of Extracellular Vesicles

    Article Title: In‐Solution Characterization of Extracellular Vesicles: A New Approach to Evaluating Antibody Binding and Surface Interactions

    doi: 10.1002/jev2.70269

    Figure Lengend Snippet: Binding measurements of increasing concentrations of IgG1‐APC and Cetuximab ALC647 to 1.02 × 10 9 p/mL CD63‐mNG‐Fc EVs. A) Changes of the hydrodynamic radius (Rh) of the complex of CD63‐mNG‐Fc EVs with IgG1‐APC in increasing concentrations of antibody, at 50 mbar ( n = 3). B) Percentage of bound IgG1‐APC by increasing concentrations of antibody to CD63‐mNG‐Fc EVs, at 50 mbar ( n = 3), r 2 = 0.9115. C) Area free/bound IgG1 antibody when incubated with CD63‐mNG‐Fc EVs on increasing concentrations, at 50 mbar ( n = 3), r 2 = 0.9997. D) Changes of the hydrodynamic radius (Rh) of the complex of CD63‐mNG‐Fc EVs with IgG1‐APC in increasing concentrations of antibody, at 100 mbar ( n = 3). E) Percentage of bound IgG1‐APC by increasing concentrations of antibody to CD63‐mNG‐Fc EVs, at 100 mbar ( n = 3), r 2 = 0.8818. F) Area free/bound IgG1 antibody when incubated with CD63‐mNG‐Fc EVs on increasing concentrations, at 100 mbar ( n = 3), r 2 = 0.9996. G) Changes of the hydrodynamic radius (Rh) of the complex of CD63‐mNG‐Fc EVs with Cetuximab in increasing antibody concentrations, at 50 mbar ( n = 3). H) Percentage of bound Cetuximab by increasing concentrations of antibody to CD63‐mNG‐Fc EVs, at 50 mbar ( n = 3), r 2 = 0.9851. I) Area free/bound Cetuximab ALC647 antibody when incubated with CD63‐mNG‐Fc EVs on increasing concentrations, at 50 mbar ( n = 3), r 2 = 0.9950 respectively. J) Changes of the hydrodynamic radius (Rh) of the complex of CD63‐mNG‐Fc EVs with Cetuximab in increasing antibody concentrations, at 100 mbar ( n = 3). K) Percentage of bound Cetuximab antibodies by increasing concentrations of antibody to CD63‐mNG‐Fc EVs, at 100 mbar ( n = 3), r 2 = 0.9537. L) Area free/bound Cetuximab ALC647 antibody when incubated with CD63‐mNG‐Fc EVs on increasing concentrations, at 100 mbar ( n = 3), r 2 = 0.9926, respectively.

    Article Snippet: EV samples (FLuoEVs, ciMSC‐EVs, Fc‐EVs, and Control EVs) were diluted in assay buffer to the respective concentration based on the particle concentration determined by NTA and/or IFCM followed by incubation with the respective antibodies: mouse anti‐human CD63 AF647 (H5C6, BD Biosciences, Cat. No. 561983, Herlev, Denmark), REA human IgG1 isotype control‐APC (REA293, Miltenyi Biotech, Cat. No. 130‐113‐434, Bergisch Gladbach, Germany) and Cetuximab (ERBITUX, 500 mg/100 mL Cetuximab, Cat. # 06185153) manually labeled with ALC647.

    Techniques: Binding Assay, Incubation